Uniting sustainability and patient convenience in self-injection devices

Ypsomed’s YpsoLoop™ Autoinjector redefines the future of self-injection with two breakthrough advances: Circular-ready sustainability design and ClickGuide™ continuous acoustic feedback.

YpsoLoop™ reduces CO₂ emissions by up to 73% in comparison to Ypsomed’s current leading autoinjector platform and enables take-back readiness through simplified material architecture: only two recyclable materials are used, one for each component. It is designed for automated disassembly and circular integration — a key enabler in pharma’s path to net zero and regulatory alignment.

On the usability side, ClickGuide™ provides a novel auditory cue throughout injection, proven to significantly increase holding time and improve patient confidence. A clinical user study showed more than 3x improved compliance compared to traditional devices (p < 0.001), setting a new benchmark in user experience.

This versatile, scalable device supports high fill volumes, can be assembled on existing lines, and is built on the proven engineering of millions of Ypsomed devices.

YpsoLoop™ is a future-ready platform that empowers both patients and partners with a next-level combination of sustainability, safety, and industrial scalability.